Supplementary file 1_The role of micro-CT in breast cancer management: a systematic review on the clinical applications of micro-CT in breast cancer and a diagnostic accuracy meta-... by Seyed Mostafa Meshkati Yazd (15198320)

“…Micro-computed tomography (micro-CT) has already exhibited clinical value, yielding high-resolution three-dimensional (3D) volumetric images. …”

Table 1_Impact of different 3D regions of interest on quantifying dynamic lumbar vertebral microstructure in ovariectomized rats—a micro-CT study.doc by Huihui Xu (778437)

“…However, whether different ROIs directly affect the results of quantitative micro-CT-based microarchitectural data is still unknown. …”

Cells lacking Cbf11 and/or Mga2 display nutrient-responsive decrease in lipid droplet (LD) content. by Anna Marešová (14375187)

Table 2_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

Table 1_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

Table 3_Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell l... by Jing Ruan (5117951)

“…</p>Aims<p>This study aims to investigate the efficacy and safety of bridging hyper-fractionated radiotherapy in combination with CAR-T therapy for relapsed/refractory diffuse large B-cell lymphoma. The potential mechanisms were explored.…”

ROC curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Loss curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Confusion matrices of (a-b) 60:40 of TRAP/TESP and (c-d) 70:30 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

ICH recognition outcome of HPDL-MIAIHD technique on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Average of HPDL-MIAIHD methodology on 70:30 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Overall flow of the HPDL-MIAIHD approach. by Naif Almakayeel (16846021)

Subjects:

outcome of HPDL-MIAIHD technique with recent methods [11–12]. by Naif Almakayeel (16846021)

Subjects:

ICH recognition outcome of HPDL-MIAIHD methodology on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

curve of HPDL-MIAIHD methodology on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

Details on database. by Naif Almakayeel (16846021)

Subjects:

Architecture of EfficientNet. by Naif Almakayeel (16846021)

Subjects:

outcome of HPDL-MIAIHD technique with recent methods. by Naif Almakayeel (16846021)

Subjects:

Average of HPDL-MIAIHD technique on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects:

PR curve of HPDL-MIAIHD method on 60:40 of TRAP/TESP. by Naif Almakayeel (16846021)

Subjects: